Can you provide the last earnings date for 10X GENOMICS INC-CLASS A?
10X GENOMICS INC-CLASS A (TXG) last reported earnings on 2/12/2026.
10X GENOMICS INC-CLASS A (TXG) Earnings History & Surprises
NASDAQ:TXG • US88025U1097
Current stock price
18.39 USD
+0.01 (+0.05%)
At close:
18.66 USD
+0.27 (+1.47%)
After Hours:
TXG Earnings overview
Past quarterly earnings results for 10X GENOMICS INC-CLASS A (TXG), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 6, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.30
- Revenue Estimate
- 147.78M
Last Reported
Most Recent- Release Date
- Feb 12, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.13
- EPS Surprise
- 39.41%
- Revenue Surprise
- 3.21%
Beat Rate
Last 8 Quarters 81%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.13 | -0.21 | 39.41% | 67.50% | 166.03M | 160.87M | 3.21% | 0.61% |
| Q3 2025 | -0.22 | -0.29 | 24.40% | 26.67% | 149.002M | 143.91M | 3.54% | -1.75% |
| Q2 2025 | 0.28 | -0.38 | 174.61% | 187.50% | 172.908M | 140.83M | 22.78% | 12.93% |
| Q1 2025 | -0.36 | -0.48 | 24.36% | 28.00% | 154.883M | 133.78M | 15.77% | 9.84% |
| Q4 2024 | -0.40 | -0.30 | -34.43% | 2.44% | 165.021M | 160.98M | 2.51% | -10.30% |
| Q3 2024 | -0.30 | -0.35 | 13.04% | 62.03% | 151.654M | 160.22M | -5.35% | -1.30% |
| Q2 2024 | -0.32 | -0.48 | 33.83% | 39.62% | 153.104M | 151.59M | 1.00% | 4.28% |
| Q1 2024 | -0.50 | -0.51 | 1.07% | -13.64% | 141.006M | 143.67M | -1.85% | 5.01% |
| Q4 2023 | -0.41 | -0.36 | -13.26% | -173.33% | 183.979M | 184.63M | -0.35% | 17.78% |
| Q3 2023 | -0.79 | -0.46 | -70.21% | -113.51% | 153.644M | 152.78M | 0.57% | 17.20% |
| Q2 2023 | -0.53 | -0.41 | -30.01% | 7.02% | 146.819M | 141.36M | 3.86% | 28.11% |
| Q1 2023 | -0.44 | -0.38 | -16.54% | -15.79% | 134.285M | 130.11M | 3.21% | 17.28% |
| Q4 2022 | -0.15 | -0.31 | 52.34% | 6.25% | 156.2M | 149.65M | 4.38% | 8.85% |
| Q3 2022 | -0.37 | -0.47 | 21.05% | -146.67% | 131.1M | 130.87M | 0.18% | 4.63% |
| Q2 2022 | -0.57 | -0.39 | -45.45% | -470.00% | 114.6M | 118.37M | -3.18% | -1.04% |
| Q1 2022 | -0.38 | -0.32 | -20.32% | -245.45% | 114.5M | 114.48M | 0.02% | 8.22% |
| Q4 2021 | -0.16 | -0.09 | -83.39% | 95.87% | 143.5M | 150.02M | -4.35% | 27.90% |
| Q3 2021 | -0.15 | -0.20 | 26.60% | 76.92% | 125.3M | 123.84M | 1.18% | 74.51% |
| Q2 2021 | -0.10 | -0.26 | 61.95% | 75.61% | 115.8M | 113.98M | 1.60% | 169.93% |
| Q1 2021 | -0.11 | -0.28 | 60.14% | 45.00% | 105.8M | 103.53M | 2.19% | 47.15% |
| Q4 2020 | -3.87 | -0.23 | -1,584.26% | - | 112.2M | 101.41M | 10.64% | - |
| Q3 2020 | -0.65 | -0.31 | -110.91% | - | 71.8M | 61.838M | 16.11% | - |
| Q2 2020 | -0.41 | -0.56 | 26.55% | - | 42.9M | 29.856M | 43.69% | - |
| Q1 2020 | -0.20 | -0.13 | -49.34% | - | 71.9M | 74.159M | -3.05% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
65.69%
Max EPS beat (4)
174.61%
Min EPS beat (4)
24.36%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
11.32%
Max Revenue beat (4)
22.78%
Min Revenue beat (4)
3.21%
Analysis
In the last 4 quarters, TXG has consistently beaten EPS estimates in all releases
TXG has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, TXG has beaten the EPS estimates by 65.7% on average.
In the last 4 quarters, TXG has beaten the revenue estimates by 11.3% on average.
Related analysis
10X GENOMICS INC-CLASS A / TXG Earnings FAQ
Did 10X GENOMICS INC-CLASS A (TXG) beat earnings estimates last quarter?
10X GENOMICS INC-CLASS A (TXG) beat EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often 10X GENOMICS INC-CLASS A beats earnings estimates?
In the last 4 quarters, 10X GENOMICS INC-CLASS A (TXG) has beaten EPS estimates in 4 out of 4 releases.